Therapeutic Strategies for the Converging TB/T2DM/HIV Epidemics (R01)

Funding Opportunity PA-17-283 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to invite applications to support innovative research to improve our understanding of innate and adaptive immune dysregulation caused by Type 2 diabetes mellitus (DM) and pre-diabetes that causes increased risk of latent tuberculosis (TB) re-activation and more severe active TB disease with more frequent treatment failure/relapse and death in the context of HIV co-infection.
Source: NIH Funding Opportunities (Notices, PA, RFA) - Category: Research Source Type: funding